Skip to main content

The Effect of Anti-CD26 Antibodies on DNA Synthesis and Cytokine Production (IL-2, IL-10 and IFN-γ) Depends on Enzymatic Activity of DP IV/CD26

  • Chapter
Cellular Peptidases in Immune Functions and Diseases

Abstract

Dipeptidyl peptidase IV (DP IV, EC 3.4.14.3) is a transmembrane type II glycoprotein present on most mammalian cells 1,2.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fleischer, B. (1994) CD26: a surface protease involved in T-cell activation../. ImnumoL 15, 180–184.

    CAS  Google Scholar 

  2. Morimoto, C. Schlossman. S. F. 11994) A key costimulatory molecule on CD4 memory T cells. The Immunologist 2, 4- -7.

    Google Scholar 

  3. Bühling, F., Junker, U., Reinhold, D.. Neubert, K., Jäger, L. Ansorge, S. (1995) Functional role of CD26 on human B lymphocytes. Immunol. Lett. 45, 47–51.

    Article  PubMed  Google Scholar 

  4. Bühling, F.. Kunz. D., Reinhold, D., Ulmer, A. J., Ernst, M., Flad, H.-D. Ansorge, S. (1994) Expression and functional role ofdipeptidyl peptidase IV on human natural killer cells. Nat. Immun. 13, 270–279.

    PubMed  Google Scholar 

  5. Yaron, A. Naider, F. (1993) Proline-dependent structural and biological properties of peptides and proteins. Olt. Rev Biochem. Mol. Biol. 28, 31–81.

    Article  CAS  Google Scholar 

  6. Ulmer, A. J., Mattern, T., Feller, A. C., Heymann, E. Flad, H.–D. (1990) CD26 antigen is a surface Dipeptidyl peptidase IV (DPPIV) as characterised by monoclonal antibodies clone TII–l9–4–7 and 4ELICl. Scand. J. Immunol. 31, 429 – 435.

    CAS  Google Scholar 

  7. Hegen, M., Niedobitek, C., Klein, C. E., Stein, H. Fleischer, B. (1990) The T cell triggering molecule Tp103 is associated with Dipeptidyl aminopeptidase IV activity. J. Immunol. 144, 2908–2914.

    CAS  Google Scholar 

  8. Mattern, T., Flad, H.-D., Feller, A. C., Heymann, E. Ulmer, A. J. (1989) Anti-DPP-IV and anti-Tal but not IOT 15 should be clustered in CDw26. In: Leukocyte Typing IV. Knapp, W., Dörken, B., Gilks, W. R., Rieber, E. P., Schmidt, R. E., Stein, H. Von Dem Borne, A. E. G. K. (Eds.), 416.

    Google Scholar 

  9. Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F. Morimoto, C. (1993) Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261, 466–469

    CAS  Google Scholar 

  10. Morimoto, C., Torimoto, Y., Levinson, G., Rudd, C. E., Schrieber, M., Dang, N. H., Letvin, N. L. Schlossman, S. F. (1989) 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J. Immunol. 143, 3430–3439.

    Google Scholar 

  11. Fleischer, B., Sturm, E., De Vries, J. E. Spits, H. (1988) Triggering of cytotoxic T lymphocytes and NK cells via the Tp103 pathway is dependent on the expression of the T cell receptor’CD3 complex..1 Immunol. 141, 1103–1107.

    CAS  Google Scholar 

  12. Hegen, M., Camerini, D. Fleischer, B. (1993) Function of dipeptidyl peptidase IV (CD26, Tp103) in transfected human T cells. Cell. Immunol. 146, 249–260.

    Google Scholar 

  13. Ansorge, S., Schön, E. Kunz, D. (1991) Membrane-bound peptidases of lymphocytes: Functional imphcations. Biomed. Biochem. Acta 50, 799–807.

    CAS  Google Scholar 

  14. Schön, E., Demuth. U. H., Barth, A. Ansorge, S. (1984) Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylprolin in T-lymphocytes. Biochem. J. 223, 255–258.

    Google Scholar 

  15. Schön. E., Eichmann, E., Grunow, R.. Jahn, S., Kiessig, S. T., Volk, H. D. Ansorge, S. (1986) Dipeptidyl peptidase IV in human T lymphocytes. An approach to the role of a membrane peptidase in the immune system. Biomed. Biochem. Acta 45, 1523–1528.

    Google Scholar 

  16. Dang, N. H., Torimoto, Y., Deusch, K., Schlossman, S. F. Morimoto, C. (1990) Comitogenic effect of solid-phase immobilized anti-I F7 on human CD4 T cell activation via CD3 and CD2 pathways,.1. Immunol. 144, 4092–4100.

    CAS  Google Scholar 

  17. Dang, N. H., Torimoto, Y., Sugita, K., Daley, J. F., Show, P., Porado, C., Schlossman, S. F. Morimoto, C (1990) Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. J. Imnumol. 145, 3963.

    CAS  Google Scholar 

  18. Dang, N. H., Torimoto, Y., Shimamura, K., Tanaka, T., Daley, J. F.. Schlossman, S F Morimoto, C. (1991) 1F7 (CD26): A marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation. J. Immunol 147, 2825–2832.

    Google Scholar 

  19. Schön, E., Born. I., Demuth, H.-U., Faust, J., Neubert, K., Stemmetzer, T., Barth, A. Ansorge, S. (1991) Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes. Biol. Chem. Hoppe Sevier 372, 305–311.

    Google Scholar 

  20. Schön. E., Demuth, H.-U., Eichmann, E., Horst, H.-J., Körner, 1.-.1., Kopp, J.. Mattem, T., Neubert, K., Noll, F., Ulmer, J. A., Barth, A. Ansorge, S. (1989) Dipeptidyl peptidase IV in human T lymphocytes Impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV. Scand. J. Immunol. 29, 127–132.

    Article  Google Scholar 

  21. Schön, E., Jahn, S., Kiessig, S. T., Demuth, H.-U., Neubert, K., Barth, A., von Baehr, R. Ansorge. S. (1987) The role of dipeptidyl peptidase IV in human T lymphocyte activation. inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eue J. Immunol. 17, 1821–1826.

    Article  Google Scholar 

  22. Torimoto, Y., Dang, N. H., Vivier, E., Tanaka, T.. Schlossman, S. F. Morimoto.. C (1991) Coassocìation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.1. Immunol_ 147. 2514–2517.

    CAS  Google Scholar 

  23. Torimoto, Y., Dang, N. H., Tanaka, T., Prado, C., Schlossman, S. F Morimoto, C. (1992) Biochemical characterization of CD26 (dipeptidyl peptidase IV): Functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. Mol. Immunol. 29, 183–192.

    Article  PubMed  CAS  Google Scholar 

  24. Schön, E., Eichmann, E., Jahn, S., Kopp, J., Volk, H. D. Ansorge, S. (1988) On the role of dipeptidyl peptidase IV (DP IV) in thew immune system. Relations to the cell cycle and lymphokine production of activated lymphocytes. Biol. Zent. bl. 107, 141–149.

    Google Scholar 

  25. Reinhold, D., Bank. U., Bühling, F., Neubert, K., Mattem, T., Ulmer, A. J., Flad, H.-D. Ansorge, S. (1993) Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against Dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells and IL-2 and IL-6 production. Immunobiol. 188, 403–414.

    CAS  Google Scholar 

  26. Reinhold, D., Bank, U., Bühling, F., Kähne, T., Kunz, D., Faust, J., Neubert, K. Ansorge, S. (1994) Inhibitors of Dipeptidyl peptidase 1V (DP IV, CD26) specifically auppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells. bnmunobiology 192, 121–136.

    Article  CAS  Google Scholar 

  27. Fleischer, B. (1987) A novel pathway of human T cell activation via a 103 kD T cell activation antigen. J. Immunol. 138, 1346–1350.

    PubMed  CAS  Google Scholar 

  28. Ansorge, S., Bühling, F., Hoffmann, T., Kähne, T., Neubert, K. Reinhold, D. (1995) DP IV/CD26 on human lymphocytes: Functional roles in cell growth and cytokine regulation. In: Dipeptidyl Peptidase IV (CD26) in metabolism and the immune response. Fleischer, B. (Eds.)R.G. Landes Company, Austin, (10)163–184.

    Google Scholar 

  29. Kähne, T., Kröning, H., Thiel. U., Ulmer, A. J., Flad, H.-D. Ansorge, S. (1996) Alterations in structure and cellular localization of molecular forms of DP IV/CD26 during T cell activation. Cell Immunol. 170. 63–70.

    Article  PubMed  Google Scholar 

  30. Kähne, T. Ansorge, S. (1994) Non-radioaktive labelling and immunoprecipitation analysis of leukocyte surface proteins using different methods of protein biotinylation. J. Immunol. Methods 168, 209–218.

    Article  PubMed  Google Scholar 

  31. Kähne, T., Neubert. K. Ansorge, S. (1995) Enzymatic activity of DP IV/CD26 is involved in PMA-induced hyperphosphorylation of p56’°“.. Immunol. Lett. 46, 189–193.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Reinhold, D. et al. (1997). The Effect of Anti-CD26 Antibodies on DNA Synthesis and Cytokine Production (IL-2, IL-10 and IFN-γ) Depends on Enzymatic Activity of DP IV/CD26. In: Ansorge, S., Langner, J. (eds) Cellular Peptidases in Immune Functions and Diseases. Advances in Experimental Medicine and Biology, vol 421. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9613-1_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9613-1_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9615-5

  • Online ISBN: 978-1-4757-9613-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics